We are live on ! Find out more
BAAM

Baker Avenue Asset Management Portfolio holdings

AUM $5.28B
1-Year Est. Return 39.19%
This Fund
S&P 500
This Quarter Est. Return
+8.03%
1 Year Est. Return
+39.19%
3 Year Est. Return
+95.57%
5 Year Est. Return
+110.74%
10 Year Est. Return
+361.6%
AUM
$1.99B
AUM Growth
+$132M
Cap. Flow
+$248M
Cap. Flow %
12.46%
Top 10 Hldgs %
31.93%
Holding
1,799
New
188
Increased
406
Reduced
477
Closed
223

Sector Composition

Rank Sector Weight
1 Technology 17.24%
2 Industrials 6.37%
3 Consumer Discretionary 5.89%
4 Financials 5.12%
5 Energy 2.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENR icon
1551
Energizer
ENR
$1.55B
$235 ﹤0.01%
7
NGVT icon
1552
Ingevity
NGVT
$2.68B
$233 ﹤0.01%
4
-2
-33% -$120
RMR icon
1553
The RMR Group
RMR
$332M
$232 ﹤0.01%
10
-6
-38% -$140
RVLV icon
1554
Revolve Group
RVLV
$1.73B
$230 ﹤0.01%
+14
New +$261
CUZ icon
1555
Cousins Properties
CUZ
$4.88B
$228 ﹤0.01%
10
-40
-80% -$837
FFIN icon
1556
First Financial Bankshares
FFIN
$4.97B
$228 ﹤0.01%
8
+1
+14% +$28
ALLK
1557
DELISTED
Allakos
ALLK
$227 ﹤0.01%
+52
New +$234
MJ icon
1558
Amplify Alternative Harvest ETF
MJ
$105M
$227 ﹤0.01%
6
SRRK icon
1559
Scholar Rock
SRRK
$6.44B
$226 ﹤0.01%
+30
New +$227
LESL icon
1560
Leslie's
LESL
$11M
$225 ﹤0.01%
+1
New +$207
MRVI icon
1561
Maravai LifeSciences
MRVI
$919M
$224 ﹤0.01%
+18
New +$243
RNAM
1562
DELISTED
Avidity Biosciences
RNAM
$222 ﹤0.01%
+20
New +$251
FATE icon
1563
Fate Therapeutics
FATE
$326M
$219 ﹤0.01%
+46
New +$254
NI icon
1564
NiSource
NI
$20.4B
$219 ﹤0.01%
8
SRDX
1565
DELISTED
Surmodics
SRDX
$219 ﹤0.01%
+7
New +$160
ZUMZ icon
1566
Zumiez
ZUMZ
$339M
$217 ﹤0.01%
+13
New +$217
MRTX
1567
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$217 ﹤0.01%
+6
New +$247
TRUP icon
1568
Trupanion
TRUP
$1.18B
$216 ﹤0.01%
+11
New +$310
NWN icon
1569
Northwest Natural Holdings
NWN
$2.12B
$215 ﹤0.01%
5
-8
-62% -$361
RLAY icon
1570
Relay Therapeutics
RLAY
$4.33B
$214 ﹤0.01%
+17
New +$211
TR icon
1571
Tootsie Roll Industries
TR
$2.98B
$212 ﹤0.01%
7
STRO icon
1572
Sutro Biopharma
STRO
$421M
$209 ﹤0.01%
+5
New +$249
GEF icon
1573
Greif
GEF
$5.04B
$207 ﹤0.01%
+3
New +$193
OLN icon
1574
Olin
OLN
$2.12B
$206 ﹤0.01%
4
NTLA icon
1575
Intellia Therapeutics
NTLA
$1.67B
$204 ﹤0.01%
+5
New +$203

Similar funds

Baker Avenue Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Baker Avenue Asset Management held 1,799 positions worth $1.99B, up 7.1% from $1.85B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Baker Avenue Asset Management deployed $248M of net new capital in Q2 2023, opening 188 new positions and adding to 406 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 72,633 shares worth $1.97M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Cboe Global Markets, an estimated $7M trimmed.

  • Baker Avenue Asset Management's largest Q2 2023 buy was Dimensional US Core Equity 2 ETF: 72,633 shares worth $1.97M.
  • Baker Avenue Asset Management added most to NVIDIA in Q2 2023, an estimated $6.19M increase.
  • Baker Avenue Asset Management's biggest Q2 2023 reduction was Cboe Global Markets, cutting an estimated $7M.
  • Baker Avenue Asset Management fully exited ABB Ltd in Q2 2023, selling an estimated $13.3M.
  • Baker Avenue Asset Management's ten largest holdings make up 32% of its $1.99B portfolio in Q2 2023.
  • Baker Avenue Asset Management opened 188 new positions and closed 223 in Q2 2023.
  • Baker Avenue Asset Management's portfolio value rose 7.1% quarter-over-quarter to $1.99B.

Based on Baker Avenue Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.